Hevolution Investment company founded in USA, Abdul ‎Rahman Al-Olayan hired as BOD member ‎

It was announced the establishment of the US Hub of Hevolution Foundation and the formation of the Board of Directors of the Hevolution Investment Company in Boston, USA, which is wholly owned by the Hevolution Charitable Foundation. The Board of Directors includes a number of prominent names with the membership of: Dr. Mahmoud Khan (Chief Executive Officer of the Hevolution Charitable Foundation) and Dr. Abdul Rahman Al- Olayan (CEO and Founder of Beta Lab), Andrew Levers (formerly Chairman of Lucid), Jim Scoba (Managing Director of MBM Capital), Lester Vegan (Attorney and Co-Founder of Cole Partners), in addition to Dr. Charlotte Kramer. ‏

The investment company aims to be a meeting point for the best minds and unique opportunities in biotechnology and technologies to enable a better healthy life and seize the best opportunities in the field. ‏

The company’s investment goals come within the efforts of the Hevolution Foundation in the field of aging, which was established in 2021 in the belief that everyone has the right to live a longer and healthier life, and it is a global catalyst, partner and supporter, on a mission to push efforts to extend a healthy human life and understanding of aging processes. With a focus on aging as a treatable process, Hevolution aims to increase the number of aging-related therapies on the market, and increase access to healthy life-prolonging therapies, also known as health span. ‏

The Hevolution Center in North America, which is based in Boston, is part of Hevolution’s plan to open centers in North America, Europe and other global locations to support an evolving global ecosystem of talent to push aging research and aging sciences forward and achieve medical breakthroughs to help humanity to live healthier and longer. ‏

The Foundation has a Board of Trustees, which is the supreme authority over its affairs and management of its affairs, and takes all necessary decisions to achieve its objectives. The charitable foundation seeks to support local and international efforts in areas aimed at improving health, including preventing and treating diseases and prolonging a healthy life span.

‏

Last month, Hevolution announced a $5 million grant to Impetus, a nonprofit science funding organization focused on life-extending research. This is within the framework of stimulating research and entrepreneurship in the field of health sciences. This pledge is complemented by Hevolution funding of $2 million in Impetus grants, supporting 14 research projects.